Eli Lilly to Acquire Ajax Therapeutics for Up to $2.3 Billion
Eli Lilly has announced its intention to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion. The acquisition aims to expand Eli Lilly's portfolio.
Results for "Ajax Therapeutics"
2 stories found
Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billion
Pharmaceutical giant Eli Lilly is set to acquire Ajax Therapeutics in a deal potentially valued at up to $2.3 billion, expanding its therapeutic portfolio.